Ohio State University, James Cancer Hospital

Columbus, Ohio 43210

1 studies enrolling now · 7 studies all time

What they study most

Anal Squamous Cell Carcinoma, B Cell Lymphoma, B Cell Non-Hodgkin's Lymphoma, Cervical Squamous Cell Carcinoma, Covid-19, Esophageal Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma, Lung Squamous Cell Carcinoma, Lymphoma, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Non-Hodgkin, Multiple Myeloma

Studies at this site

• Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple Myeloma — Recruiting now
• Low-Dose Radiotherapy For Patients With SARS-COV-2 (COVID-19) Pneumonia — Running, not enrolling
• A Study of Azenosertib (ZN-c3) in Women With Recurrent or Persistent Uterine Serous Carcinoma — Completed
• CRISPR-Edited Allogeneic Anti-CD19 CAR-T Cell Therapy for Relapsed/Refractory B Cell Non-Hodgkin Lymphoma (ANTLER) — Status unconfirmed
• Brentuximab Vedotin and Lenalidomide for Relapsed or Refractory Diffuse Large B-cell Lymphoma — Completed
• Efficacy of XL184 (Cabozantinib) in Advanced Medullary Thyroid Cancer — Completed
• Oral Rigosertib for Squamous Cell Carcinoma — Completed